Papers/PMID:20501771
Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2010The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
cyanocob(III)alamin — increases prostate cancer incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Vitamin B(12) and (in cohort studies) folate were associated with increased prostate cancer risk.”
Quoted verbatim from Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.. - Study
- meta-analysis
- Population
- Men in a nested case-control study (ProtecT, 1,461 cases and 1,507 controls) pooled with published studies; exposure is circulating B12 concentration
Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.2010PMID:20501771Permalink